News nuggets you might have missedWhile we are all trying to keep up, sometimes the most important stories that can affect our industry are shoved off to the... Protecting your travel agency in ...
SAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.1 billion market cap biotech company with a robust current ratio of 3.72, reported selling shares worth $48,029 ...
SAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.03 billion market cap biotech company, executed sales of common stock valued at a total of $46,360 over two ...